Corbus Pharma (CRBP) Lower after Entering Agreement with Cantor on $35M Common Stock Offering
Tweet Send to a Friend
Corbus Pharma (NASDAQ: CRBP) is trading down 6% after-hours after the company disclosed it entered into a Controlled ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
